Envestnet Asset Management Inc Deciphera Pharmaceuticals, Inc. Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$13.58 - $17.36 $41,079 - $52,514
3,025 Added 14.54%
23,832 $374,000
Q4 2023

Feb 13, 2024
BUY
$10.11 - $16.54 $1,941 - $3,175
192 Added 0.93%
20,807 $335,000
Q3 2023

Nov 13, 2023
BUY
$12.46 - $15.48 $107,779 - $133,902
8,650 Added 72.29%
20,615 $262,000
Q2 2023

Aug 04, 2023
SELL
$13.28 - $15.96 $8,817 - $10,597
-664 Reduced 5.26%
11,965 $168,000
Q1 2023

May 11, 2023
BUY
$14.26 - $22.1 $180,089 - $279,100
12,629 New
12,629 $195,000

Others Institutions Holding DCPH

# of Institutions
6
Shares Held
293K
Call Options Held
500
Put Options Held
0
View Full List

About Deciphera Pharmaceuticals, Inc.

DCPH Quotes by TradingView
  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email